CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has won a prestigious R&D 100 Award for its Qubit quantitation platform. The Qubit platform, developed by Invitrogen’s Molecular Probes business, has modernized DNA, RNA and protein quantitation for research scientists, changing how they work in the lab.
